Crossref
0179 Efficacy of dupilumab in Chinese atopic dermatitis patients: A real-world multicentre study
Journal of Investigative Dermatology · 2026-08 · 146 (8) · S32
DOI: 10.1016/j.jid.2026.06.210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2026-08. Verfasst von R. Wang und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wang, R., Li, H., & Wang, Y. (2026). 0179 Efficacy of dupilumab in Chinese atopic dermatitis patients: A real-world multicentre study. Journal of Investigative Dermatology, 146(8), S32. https://doi.org/10.1016/j.jid.2026.06.210
Vancouver
Wang R, Li H, Wang Y. 0179 Efficacy of dupilumab in Chinese atopic dermatitis patients: A real-world multicentre study. Journal of Investigative Dermatology. 2026;146(8):S32. doi:10.1016/j.jid.2026.06.210
BibTeX
@article{Wang2026,
author = {Wang, R. and Li, H. and Wang, Y.},
title = {0179 Efficacy of dupilumab in Chinese atopic dermatitis patients: A real-world multicentre study},
journal = {Journal of Investigative Dermatology},
year = {2026},
volume = {146},
number = {8},
pages = {S32},
doi = {10.1016/j.jid.2026.06.210}
}
EUVIMED